Lung Cancer Update

Dr. Neil Love

This series bridges the gap between research and patient care by providing medical oncologists and hematologists ongoing access to the perspectives and opinions of national and international research leaders with an expertise in thoracic oncology.

  • 1 hour 2 seconds
    EGFR-Mutant Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances

    Dr Enriqueta Felip from the Vall d’Hebron Institute of Oncology in Barcelona, Spain, and Dr Helena Yu from Memorial Sloan Kettering Cancer Center in New York, New York, discuss current and emerging treatment approaches for patients with EGFR-mutant non-small cell lung cancer. 

    CME information and select publications here

    6 February 2025, 2:00 pm
  • 48 minutes 3 seconds
    Cases from the Community: Integrating New Research Findings into Current Practice — Lung Cancer

    Dr Edward B Garon shares his perspectives on the evolving therapeutic landscape for patients with lung cancer.

    13 December 2024, 5:06 pm
  • 58 minutes 47 seconds
    Meet The Professor: Current and Future Use of Nontargeted Therapy for Metastatic Non-Small Cell Lung Cancer — A 2024 World Conference on Lung Cancer

    Dr Heather Wakelee from Stanford University School of Medicine in California discusses the implications of recent datasets for the current and future use of nontargeted therapy for metastatic non-small cell lung cancer.

    11 December 2024, 5:25 pm
  • 1 hour 12 seconds
    The Implications of Recent Datasets for the Current and Future Management of Lung Cancer — A Review of Information from ESMO Congress 2024 and Other Conferences

    Dr Suresh S Ramalingam from the Emory University School of Medicine in Atlanta, Georgia and Dr Gregory J Riely from Memorial Sloan Kettering Cancer Center in New York, New York discuss the implications of recent data sets for the current and future management of lung cancer.

    25 November 2024, 6:04 pm
  • 1 hour 5 minutes
    Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care  — Lung Cancer

    Specialist clinical investigators share their perspectives on the evolving therapeutic landscape for patients with lung cancer.

    16 November 2024, 2:43 am
  • 54 minutes 40 seconds
    Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Lung Cancer from Recent Major Conferences

    Dr Stephen V Liu from Georgetown University Hospital in Washington, DC, reviews recently presented data with and newly approved therapies for localized and advanced lung cancers.

    7 November 2024, 5:03 pm
  • 42 minutes 46 seconds
    The Implications of Recent Datasets for the Current and Future Management of Small Cell Lung Cancer — A 2024 World Conference on Lung Cancer Review

    Dr Jacob Sands from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent presentations on approved and investigational therapies in small cell lung cancer from the 2024 World Conference on Lung Cancer.

    23 October 2024, 5:48 pm
  • 1 hour 8 seconds
    The Implications of Recent Datasets for the Current and Future Use of Nontargeted Therapy for Metastatic Non-Small Cell Lung Cancer

    Dr Edward Garon from UCLA Health Jonsson Comprehensive Cancer Center and Dr Luis Paz-Ares from the Spanish National Oncology Research Center in Madrid share their perspectives on recent datasets from the 2024 World Conference on Lung Cancer on the management of non-small cell lung cancer without actionable genomic alterations.

    16 October 2024, 5:49 pm
  • 58 minutes 14 seconds
    The Implications of Recent Datasets for the Current and Future Management of Non-Small Cell Lung Cancer with Actionable Targets Beyond EGFR

    Dr Ibiayi Dagogo-Jack from Massachusetts General Hospital in Boston and Dr Corey J Langer from the Abramson Cancer Center in Philadelphia, Pennsylvania, discuss the implications of recent datasets for the current and future management of non-small cell lung cancer with actionable targets beyond EGFR.

    8 October 2024, 5:37 pm
  • 58 minutes 19 seconds
    The Implications of Recent Datasets for the Current and Future Management of Non-Small Cell Lung Cancer with EGFR Mutations

    Dr Joshua K Sabari from the NYU Langone Health Perlmutter Cancer Center and Dr Helena Yu from Memorial Sloan Kettering Cancer Center in New York, New York, summarize the treatment landscape for non-small cell lung cancer with EGFR mutations.

    2 October 2024, 4:53 pm
  • 59 minutes 20 seconds
    Inside the Issue: Optimizing the Diagnosis and Treatment of Neuroendocrine Tumors

    Dr Pamela Kunz from the Yale School of Medicine and Yale Cancer Center in New Haven, Connecticut, and Dr Simron Singh from the Odette Cancer Centre and Sunnybrook Health Sciences Centre in Toronto, Ontario, Canada, discuss optimizing the diagnosis and treatment of neuroendocrine tumors.

    19 September 2024, 1:23 pm
  • More Episodes? Get the App